|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/39558 | (2013.01) |
| C07K 16/28 | (2006.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61K2039/54 | (2013.01) | ||
| C07K 16/30 | (2006.01) | ||
| A61P 37/06 | (2018.01) | ||
| A61K 39/3955 | (2013.01) | ||
| C07K2319/24 | (2013.01) | ||
| C07K 16/3007 | (2013.01) | ||
| C07K 16/2887 | (2013.01) | ||
| A61K2039/505 | (2013.01) | ||
| A61K2039/545 | (2013.01) | ||
| C07K 16/2809 | (2013.01) | ||
| C07K2319/00 | (2013.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| C07K2317/31 | (2013.01) | ||
| A61K2039/507 | (2013.01) |
| (11) | Number of the document | 3387015 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16810283.8 |
| Date of filing the European patent application | 2016-12-06 | |
| (97) | Date of publication of the European application | 2018-10-17 |
| (45) | Date of publication and mention of the grant of the patent | 2021-10-27 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2016/079800 |
| Date | 2016-12-06 |
| (87) | Number | WO 2017/097723 |
| Date | 2017-06-15 |
| (30) | Number | Date | Country code |
| 15198715 | 2015-12-09 | EP | |
| 16172739 | 2016-06-02 | EP | |
| 16193151 | 2016-10-10 | EP |
| (72) |
BACAC, Marina , CH
EVERS, Stefan , CH
KLEIN, Christian , CH
PISA, Pavel , CH
ROSSMANN, Eva , CH
SARO, Jose , CH
UMAÑA, Pablo , CH
|
| (73) |
F. Hoffmann-La Roche AG ,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | TYPE II ANTI-CD20 ANTIBODY FOR REDUCING FORMATION OF ANTI-DRUG ANTIBODIES |
| TYPE II ANTI-CD20 ANTIBODY FOR REDUCING FORMATION OF ANTI-DRUG ANTIBODIES |